Treatment with Recombinant Interferon-Alpha-2C: Multiple Myeloma and Thrombocythaemia in Myeloproliferative DiseasesHeinz Ludwig, R. Flener, Werner Linkesch et al.|Oncology|2009Cited by 22
Combined alpha-2C-interferon/VMCP polychemotherapy versus VMCP polychemotherapy as induction therapy in multiple myeloma: a prospective randomized trial.Werner Scheithauer, Heinz Ludwig, Agostino Cortelezzi et al.|PubMed|1989Cited by 12
[Interferon in the treatment of multiple myeloma].R. Kuzmits, Werner Scheithauer, R. Flener et al.|PubMed|1985Cited by 3